United Therapeutics Corporation (UTHR) is a leading biotechnology firm focused on the development and commercialization of innovative therapies for patients with chronic and life-threatening conditions, particularly in the pulmonary hypertension and organ transplant sectors. Headquartered in Silver Spring, Maryland, the company leverages its robust pipeline and advanced technologies to address significant medical needs both in the United States and globally. With a commitment to transforming medical care through unique solutions, United Therapeutics is poised for continued growth and impact in the healthcare landscape.